Administration of VEGF (sNN0029) using an implanted drug delivery system for adose escalation study in patients with Amyotrophic Lateral Sclerosis.

Administration of VEGF (sNN0029) using an implanted drug delivery system for adose escalation study in patients with Amyotrophic Lateral Sclerosis.

Investments > €500k
United Kingdom
Motor neurone diseases
2016

 

 

Post
Filter